PDB Short entry for 1AUT HEADER HYDROLASE/HYDROLASE INHIBITOR 08-JUN-96 1AUT TITLE HUMAN ACTIVATED PROTEIN C COMPND MOL_ID: 1; COMPND 2 MOLECULE: ACTIVATED PROTEIN C; COMPND 3 CHAIN: C; COMPND 4 SYNONYM: AUTOPROTHROMBIN IIA; COMPND 5 EC: 3.4.21.69; COMPND 6 OTHER_DETAILS: GLA-DOMAIN REMOVED BY CHYMOTRYPSIN; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: ACTIVATED PROTEIN C; COMPND 9 CHAIN: L; COMPND 10 SYNONYM: AUTOPROTHROMBIN IIA; COMPND 11 EC: 3.4.21.69; COMPND 12 OTHER_DETAILS: GLA-DOMAIN REMOVED BY CHYMOTRYPSIN SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 ORGAN: PLASMA; SOURCE 6 TISSUE: PLASMA; SOURCE 7 MOL_ID: 2; SOURCE 8 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 9 ORGANISM_COMMON: HUMAN; SOURCE 10 ORGANISM_TAXID: 9606; SOURCE 11 ORGAN: PLASMA; SOURCE 12 TISSUE: PLASMA KEYWDS SERINE PROTEINASE, PLASMA CALCIUM BINDING, GLYCOPROTEIN, HYDROLASE- KEYWDS 2 HYDROLASE INHIBITOR COMPLEX, BLOOD CLOTTING EXPDTA X-RAY DIFFRACTION AUTHOR T.MATHER,V.OGANESSYAN,P.HOF,W.BODE,R.HUBER,S.FOUNDLING,C.ESMON REVDAT 6 03-APR-24 1AUT 1 REMARK REVDAT 5 13-MAR-24 1AUT 1 COMPND SOURCE REMARK LINK REVDAT 4 20-JUN-12 1AUT 1 HETNAM REVDAT 3 13-JUL-11 1AUT 1 VERSN REVDAT 2 24-FEB-09 1AUT 1 VERSN REVDAT 1 20-AUG-97 1AUT 0 JRNL AUTH T.MATHER,V.OGANESSYAN,P.HOF,R.HUBER,S.FOUNDLING,C.ESMON, JRNL AUTH 2 W.BODE JRNL TITL THE 2.8 A CRYSTAL STRUCTURE OF GLA-DOMAINLESS ACTIVATED JRNL TITL 2 PROTEIN C. JRNL REF EMBO J. V. 15 6822 1996 JRNL REFN ISSN 0261-4189 JRNL PMID 9003757 REMARK 2 REMARK 2 RESOLUTION. 2.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PROLSQ REMARK 3 AUTHORS : KONNERT,HENDRICKSON REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 8.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 COMPLETENESS FOR RANGE (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 11715 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : 0.184 REMARK 3 FREE R VALUE : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2635 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 30 REMARK 3 SOLVENT ATOMS : 146 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 26.70 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : 0.012 ; 0.020 REMARK 3 ANGLE DISTANCE (A) : 2.072 ; 0.040 REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : NULL ; 0.050 REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : NULL ; 0.010 REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : NULL ; 0.100 REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : NULL ; 0.200 REMARK 3 MULTIPLE TORSION (A) : NULL ; 0.200 REMARK 3 H-BOND (X...Y) (A) : NULL ; 0.200 REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : NULL ; 10.000 REMARK 3 STAGGERED (DEGREES) : NULL ; 15.000 REMARK 3 TRANSVERSE (DEGREES) : NULL ; 45.000 REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; 2.500 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 THE FOLLOWING SEGMENTS ARE DISORDERED AND ARE MODELED REMARK 3 STEREOCHEMICALLY TO PRESERVE CHAIN CONTINUITY: REMARK 3 C 60 - C 62, C 148 - C 151, L 70 - L 77. REMARK 3 REMARK 3 HIS L 107 IS IN A TIGHT TURN AND HAS TORSION ANGLES OUTSIDE REMARK 3 THE EXPECTED RAMACHANDRAN REGIONS. THE STRAIN IS REMARK 3 STABILIZED BY A HYDROGEN BOND TO ASN L 102. REMARK 3 REMARK 3 RESIDUE BHD L 71 HAS BEEN SHOWN TO BE BETA-HYDROXYLATED REMARK 3 ALTHOUGH IT IS IN A DISORDERED SEGMENT OF THIS STRUCTURE. REMARK 3 THE HYDROXYL GROUP IS NOT VISIBLE. REMARK 4 REMARK 4 1AUT COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000171285. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 05-FEB-95 REMARK 200 TEMPERATURE (KELVIN) : 285 REMARK 200 PH : 4.7 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : GRAPHITE(002) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 12294 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.800 REMARK 200 RESOLUTION RANGE LOW (A) : 8.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 92.4 REMARK 200 DATA REDUNDANCY : 2.000 REMARK 200 R MERGE (I) : 0.12600 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.90 REMARK 200 COMPLETENESS FOR SHELL (%) : 85.5 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MAIN V. 95 REMARK 200 STARTING MODEL: FACTOR XA POLY-ALA REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 61.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.14 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M CITRATE, 20% ISOPROPANOL 2% PEG REMARK 280 20000 PH 4.7 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 28.53000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 50.61500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 44.80000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 50.61500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 28.53000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 44.80000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, L REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS C 245 REMARK 465 GLU C 246 REMARK 465 ALA C 247 REMARK 465 PRO C 248 REMARK 465 GLN C 249 REMARK 465 LYS C 250 REMARK 465 SER C 251 REMARK 465 TRP C 252 REMARK 465 ALA C 253 REMARK 465 PRO C 254 REMARK 465 SER L 42 REMARK 465 LYS L 43 REMARK 465 HIS L 44 REMARK 465 VAL L 45 REMARK 465 ASP L 46 REMARK 465 GLY L 47 REMARK 465 ASP L 48 REMARK 465 ARG L 147 REMARK 465 MET L 148 REMARK 465 GLU L 149 REMARK 465 LYS L 150 REMARK 465 LYS L 151 REMARK 465 ARG L 152 REMARK 465 SER L 153 REMARK 465 HIS L 154 REMARK 465 LEU L 155 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASP C 244 O REMARK 470 BHD L 71 OB REMARK 470 LYS L 146 O REMARK 475 REMARK 475 ZERO OCCUPANCY RESIDUES REMARK 475 THE FOLLOWING RESIDUES WERE MODELED WITH ZERO OCCUPANCY. REMARK 475 THE LOCATION AND PROPERTIES OF THESE RESIDUES MAY NOT REMARK 475 BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 475 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE) REMARK 475 M RES C SSEQI REMARK 475 ASP C 60 REMARK 475 GLU C 60A REMARK 475 SER C 61 REMARK 475 LYS C 62 REMARK 475 LYS C 149 REMARK 475 GLU C 149A REMARK 475 ALA C 149B REMARK 475 LYS C 149C REMARK 475 ARG C 149D REMARK 475 ASN C 150 REMARK 475 ARG C 151 REMARK 475 BHD L 71 REMARK 475 GLY L 72 REMARK 475 ILE L 73 REMARK 475 GLY L 74 REMARK 475 SER L 75 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 LYS C 37 CB CG CD CE NZ REMARK 480 LYS C 63 N CA CB CG CD CE NZ REMARK 480 ARG C 75 CG CD NE CZ NH1 NH2 REMARK 480 LYS C 96 CD CE NZ REMARK 480 GLU C 148 C O CB CG CD OE1 OE2 REMARK 480 MET C 175 CG SD CE REMARK 480 ARG C 243 CB CG CD NE CZ NH1 NH2 REMARK 480 ILE L 70 CB CG1 CG2 CD1 REMARK 480 PHE L 76 CB CG CD1 CD2 CE1 CE2 CZ REMARK 480 ARG L 91 CB CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OD2 ASP C 125 O HOH C 300 1.61 REMARK 500 OG SER C 195 C3 0G6 C 1 1.97 REMARK 500 CE MET C 21 CD ARG C 151 2.00 REMARK 500 OE1 GLN C 131 O HOH C 323 2.12 REMARK 500 OD1 ASP C 125 O HOH C 263 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 HZ2 LYS C 159 O MET C 172 4556 1.59 REMARK 500 OE2 GLU C 148 CB SER L 77 4456 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR C 71 -53.54 -134.91 REMARK 500 GLU C 129 -69.25 -122.55 REMARK 500 ASN C 150 44.87 -178.20 REMARK 500 THR C 152 -49.34 -141.66 REMARK 500 PHE C 153 60.84 -103.29 REMARK 500 CYS C 191 -163.55 -167.02 REMARK 500 PRO L 54 32.59 -72.68 REMARK 500 CYS L 64 13.15 53.97 REMARK 500 HIS L 107 -87.12 -128.33 REMARK 500 LEU L 131 -40.02 -130.43 REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 REMARK 600 THE UNBOUND FORM OF THE INHIBITOR IS D-PHE-PRO-ARG- REMARK 600 CHLOROMETHYLKETONE. UPON REACTION WITH PROTEIN IT FORMS TWO REMARK 600 COVALENT BONDS: 1) A COVALENT BOND TO SER 195 FORMING A HEMIKETAL REMARK 600 AR7 AND 2) A COVALENT BOND TO NE2 OF HIS 57 REMARK 630 REMARK 630 MOLECULE TYPE: PEPTIDE-LIKE INHIBITOR REMARK 630 MOLECULE NAME: D-PHENYLALANYL-N-[(2S,3S)-6-{[AMINO(IMINIO)METHYL] REMARK 630 AMINO}-1-CHLORO-2-HYDROXYHEXAN-3-YL]-L-PROLINAMIDE REMARK 630 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 630 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 630 REMARK 630 M RES C SSSEQI REMARK 630 0G6 C 1 REMARK 630 SOURCE: NULL REMARK 630 TAXONOMY: NULL REMARK 630 SUBCOMP: DPN PRO AR7 0QE REMARK 630 DETAILS: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 0G6 C 1 REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE CHYMOTRYPSIN NUMBERING (RATHER THAN SEQUENTIAL) SYSTEM IS USED REMARK 999 HERE, BASED ON THE TOPOLOGICAL ALIGNMENT WITH THE STRUCTURE OF REMARK 999 CHYMOTRYPSIN (W.BODE ET AL., 1989, EMBO J.8, 3467-3475). DBREF 1AUT C 16 254 UNP P04070 PRTC_HUMAN 212 461 DBREF 1AUT L 42 155 UNP P04070 PRTC_HUMAN 84 197 SEQRES 1 C 250 LEU ILE ASP GLY LYS MET THR ARG ARG GLY ASP SER PRO SEQRES 2 C 250 TRP GLN VAL VAL LEU LEU ASP SER LYS LYS LYS LEU ALA SEQRES 3 C 250 CYS GLY ALA VAL LEU ILE HIS PRO SER TRP VAL LEU THR SEQRES 4 C 250 ALA ALA HIS CYS MET ASP GLU SER LYS LYS LEU LEU VAL SEQRES 5 C 250 ARG LEU GLY GLU TYR ASP LEU ARG ARG TRP GLU LYS TRP SEQRES 6 C 250 GLU LEU ASP LEU ASP ILE LYS GLU VAL PHE VAL HIS PRO SEQRES 7 C 250 ASN TYR SER LYS SER THR THR ASP ASN ASP ILE ALA LEU SEQRES 8 C 250 LEU HIS LEU ALA GLN PRO ALA THR LEU SER GLN THR ILE SEQRES 9 C 250 VAL PRO ILE CYS LEU PRO ASP SER GLY LEU ALA GLU ARG SEQRES 10 C 250 GLU LEU ASN GLN ALA GLY GLN GLU THR LEU VAL THR GLY SEQRES 11 C 250 TRP GLY TYR HIS SER SER ARG GLU LYS GLU ALA LYS ARG SEQRES 12 C 250 ASN ARG THR PHE VAL LEU ASN PHE ILE LYS ILE PRO VAL SEQRES 13 C 250 VAL PRO HIS ASN GLU CYS SER GLU VAL MET SER ASN MET SEQRES 14 C 250 VAL SER GLU ASN MET LEU CYS ALA GLY ILE LEU GLY ASP SEQRES 15 C 250 ARG GLN ASP ALA CYS GLU GLY ASP SER GLY GLY PRO MET SEQRES 16 C 250 VAL ALA SER PHE HIS GLY THR TRP PHE LEU VAL GLY LEU SEQRES 17 C 250 VAL SER TRP GLY GLU GLY CYS GLY LEU LEU HIS ASN TYR SEQRES 18 C 250 GLY VAL TYR THR LYS VAL SER ARG TYR LEU ASP TRP ILE SEQRES 19 C 250 HIS GLY HIS ILE ARG ASP LYS GLU ALA PRO GLN LYS SER SEQRES 20 C 250 TRP ALA PRO SEQRES 1 L 114 SER LYS HIS VAL ASP GLY ASP GLN CYS LEU VAL LEU PRO SEQRES 2 L 114 LEU GLU HIS PRO CYS ALA SER LEU CYS CYS GLY HIS GLY SEQRES 3 L 114 THR CYS ILE BHD GLY ILE GLY SER PHE SER CYS ASP CYS SEQRES 4 L 114 ARG SER GLY TRP GLU GLY ARG PHE CYS GLN ARG GLU VAL SEQRES 5 L 114 SER PHE LEU ASN CYS SER LEU ASP ASN GLY GLY CYS THR SEQRES 6 L 114 HIS TYR CYS LEU GLU GLU VAL GLY TRP ARG ARG CYS SER SEQRES 7 L 114 CYS ALA PRO GLY TYR LYS LEU GLY ASP ASP LEU LEU GLN SEQRES 8 L 114 CYS HIS PRO ALA VAL LYS PHE PRO CYS GLY ARG PRO TRP SEQRES 9 L 114 LYS ARG MET GLU LYS LYS ARG SER HIS LEU MODRES 1AUT BHD L 71 ASP (3S)-3-HYDROXY-L-ASPARTIC ACID HET BHD L 71 9 HET 0G6 C 1 38 HETNAM BHD (3S)-3-HYDROXY-L-ASPARTIC ACID HETNAM 0G6 D-PHENYLALANYL-N-[(2S,3S)-6-{[AMINO(IMINIO) HETNAM 2 0G6 METHYL]AMINO}-1-CHLORO-2-HYDROXYHEXAN-3-YL]-L- HETNAM 3 0G6 PROLINAMIDE HETSYN BHD BETA-HYDROXYASPARTIC ACID HETSYN 0G6 PPACK FORMUL 2 BHD C4 H7 N O5 FORMUL 3 0G6 C21 H34 CL N6 O3 1+ FORMUL 4 HOH *146(H2 O) HELIX 1 1 ALA C 56 CYS C 58 5 3 HELIX 2 2 SER C 126 ARG C 128C 1 6 HELIX 3 3 HIS C 165 VAL C 171 1 7 HELIX 4 4 VAL C 231 ARG C 233 5 3 HELIX 5 5 LEU C 235 ILE C 242 1 8 HELIX 6 6 ASP L 101 GLY L 104 5 4 SHEET 1 A 7 LEU C 81 ASP C 84 0 SHEET 2 A 7 LEU C 65 LEU C 68 -1 N LEU C 68 O LEU C 81 SHEET 3 A 7 GLN C 30 LEU C 34 -1 N LEU C 34 O LEU C 65 SHEET 4 A 7 LEU C 40 HIS C 48 -1 N ALA C 44 O VAL C 31 SHEET 5 A 7 TRP C 51 THR C 54 -1 N LEU C 53 O VAL C 45 SHEET 6 A 7 ALA C 104 LEU C 108 -1 N LEU C 106 O VAL C 52 SHEET 7 A 7 ILE C 85 VAL C 90 -1 N PHE C 89 O LEU C 105 SHEET 1 B 2 GLU C 135 GLY C 140 0 SHEET 2 B 2 ASN C 156 PRO C 161 -1 N ILE C 160 O THR C 136 SHEET 1 C 4 MET C 180 ALA C 183 0 SHEET 2 C 4 GLY C 226 LYS C 230 -1 N TYR C 228 O LEU C 181 SHEET 3 C 4 THR C 206 TRP C 215 -1 N TRP C 215 O VAL C 227 SHEET 4 C 4 PRO C 198 PHE C 203 -1 N PHE C 203 O THR C 206 SHEET 1 D 2 GLY L 67 ILE L 70 0 SHEET 2 D 2 SER L 77 CYS L 80 -1 N ASP L 79 O THR L 68 SHEET 1 E 2 TYR L 108 GLU L 111 0 SHEET 2 E 2 ARG L 116 SER L 119 -1 N SER L 119 O TYR L 108 SHEET 1 F 2 TYR L 124 LEU L 126 0 SHEET 2 F 2 CYS L 133 PRO L 135 -1 N HIS L 134 O LYS L 125 SSBOND 1 CYS C 42 CYS C 58 1555 1555 2.02 SSBOND 2 CYS C 122 CYS L 141 1555 1555 2.03 SSBOND 3 CYS C 168 CYS C 182 1555 1555 2.00 SSBOND 4 CYS C 191 CYS C 220 1555 1555 2.03 SSBOND 5 CYS L 50 CYS L 69 1555 1555 2.02 SSBOND 6 CYS L 59 CYS L 64 1555 1555 2.03 SSBOND 7 CYS L 63 CYS L 78 1555 1555 2.03 SSBOND 8 CYS L 80 CYS L 89 1555 1555 2.03 SSBOND 9 CYS L 98 CYS L 109 1555 1555 2.03 SSBOND 10 CYS L 105 CYS L 118 1555 1555 2.02 SSBOND 11 CYS L 120 CYS L 133 1555 1555 2.02 LINK C3 0G6 C 1 NE2 HIS C 57 1555 1555 2.04 LINK C2 0G6 C 1 OG SER C 195 1555 1555 1.39 LINK C ILE L 70 N BHD L 71 1555 1555 1.33 LINK C BHD L 71 N GLY L 72 1555 1555 1.33 SITE 1 AC1 16 HOH C 4 HIS C 57 THR C 98 THR C 99 SITE 2 AC1 16 ASN C 174 ASP C 189 ALA C 190 CYS C 191 SITE 3 AC1 16 GLU C 192 GLY C 193 SER C 195 SER C 214 SITE 4 AC1 16 TRP C 215 GLY C 216 GLY C 219 HOH C 265 CRYST1 57.060 89.600 101.230 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017525 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011161 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009878 0.00000